Clinical Trial Update: Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating radiofrequency ablation to control blood pressure and disease progression in autosomal dominant polycystic kidney disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Hypertension

Snippet

Sponsor: Mei changlin | Conditions: Autosomal Dominant Polycystic Kidney Disease, Hypertension | Phase 2 | Status: UNKNOWN